➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
McKesson
Baxter
Medtronic

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RESTASIS MULTIDOSE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Restasis Multidose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00348335 ↗ Efficacy of Topical Cyclosporin for Ocular Rosacea Completed Allergan Phase 4 2006-06-01 The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00348335 ↗ Efficacy of Topical Cyclosporin for Ocular Rosacea Completed Ophthalmic Consultants of Long Island Phase 4 2006-06-01 The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
NCT00349440 ↗ Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy Completed Innovative Medical Phase 4 2006-09-01 The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK or photorefractive keratectomy (PRK).
NCT00399061 ↗ Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms Completed Innovative Medical Phase 4 2006-11-01 The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
NCT00405431 ↗ Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? Completed Allergan N/A 2004-03-01 The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
NCT00405431 ↗ Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery? Completed Wills Eye N/A 2004-03-01 The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Restasis Multidose

Condition Name

Condition Name for Restasis Multidose
Intervention Trials
Dry Eye Syndromes 12
Dry Eye 9
Dry Eye Syndrome 5
Dry Eye Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Restasis Multidose
Intervention Trials
Keratoconjunctivitis Sicca 31
Dry Eye Syndromes 31
Syndrome 10
Eye Diseases 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Restasis Multidose

Trials by Country

Trials by Country for Restasis Multidose
Location Trials
United States 55
Korea, Republic of 7
Thailand 2
Singapore 2
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Restasis Multidose
Location Trials
California 8
Massachusetts 6
New York 5
Tennessee 4
Texas 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Restasis Multidose

Clinical Trial Phase

Clinical Trial Phase for Restasis Multidose
Clinical Trial Phase Trials
Phase 4 15
Phase 3 10
Phase 2 11
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Restasis Multidose
Clinical Trial Phase Trials
Completed 29
Recruiting 7
Not yet recruiting 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Restasis Multidose

Sponsor Name

Sponsor Name for Restasis Multidose
Sponsor Trials
Allergan 12
Innovative Medical 6
Huons Co.,Ltd. 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Restasis Multidose
Sponsor Trials
Industry 34
Other 25
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Johnson and Johnson
Harvard Business School
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.